Abstract:R-Ras, a member of the Ras superfamily, is expressed in a wide variety of tissues and regulates cell adhesion, migration, differentiation and apoptosis. Research has raised the possibility that R-Ras may function as a positive regulator of cell proliferation and transformation in the breast. To understand the possible role of R-Ras in breast epithelial carcinogenesis, the expression and activation of R-Ras were detected in each of 69 pairs of breast cancer tissues and normal tumor-adjacent tissue samples by qRT-PCR, western blot analysis and GST pull down assay; 12 available cell lines were also subjected to western blot analysis and GST pull down assay. To further address the role of R-Ras in transformation-related phenotype formation of breast cancer cell line MCF-7 in vitro, R-Ras38V, a constitutively activated mutant of R-Ras, was transfected into MCF-7 cells, and the cell proliferation, migration and cell cycle distribution were analyzed. The results showed that although there was slight difference in the protein expression of R-Ras between the breast cancer tissues and normal tissues, the activation of R-Ras was reduced in 63.8% of the cancer tissues when compared to the normal tissue samples. In addition, the results also showed that R-Ras38V inhibited cell proliferation, migration and cell cycle progression in the presence of serum. Contradicting the positive association reported in previous studies, our results indicate that R-Ras activation may negatively regulate the transformation of breast epithelial cells, and the loss of activation of R-Ras may be involved in the carcinogenesis of breast cancer. To solve this controversy, further independent studies are needed to validate our study results.

Signaling Passway and Related Biological Function Mediated by R-Ras

Major Physiological Signaling Pathways in the Regulation of Cell Proliferation and Survival

Rencent Advances in the Function of R-Ras

Rho Subfamily Proteins in Cancer Invasion and Metastasis

Microrna-148A-3p Inhibited the Proliferation and Epithelial-Mesenchymal Transition Progression of Non-Small-cell Lung Cancer Via Modulating Ras/MAPK/Erk Signaling

RAS signaling in carcinogenesis, cancer therapy and resistance mechanisms

Negative Association of R-Ras Activation and Breast Cancer Development.

The Mechanisms Of Diras Family Members In Role Of Tumor Suppressor

Function, significance and regulation of Rap1b in malignancy

Epigenetic Silencing of a Ca2+-regulated Ras GTPase-activating Protein RASAL Defines a New Mechanism of Ras Activation in Human Cancers

RAS Signalling in the Colorectum in Health and Disease

Roles of Rap1 Signaling in Tumor Cell Migration and Invasion

RAS signalling in the colorectum in health and disease.

Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway

Potential Drug Targets Based on the Ras Signal Transduction Pathways:a Review

RASAL1 Expression and Ras Activity with Gastrointestinal Tumors: a Review

RAS oncogenes: weaving a tumorigenic web

One Step Closer to Targeting RAS.

Ras superfamily GTPase activating proteins in cancer: Potential therapeutic targets?

Mechanistic regulation of epithelial-to-mesenchymal transition through RAS signaling pathway and therapeutic implications in human cancer

Tumor Suppression of Ras GTPase-Activating Protein RASA5 Through Antagonizing Ras Signaling Perturbation in Carcinomas.